Authors


Deepali Dixit, PharmD

Latest:

Managing Toxicities Associated With Immune Checkpoint Inhibitors

Although ICIs have demonstrated excellent efficacy, they also have been associated with unique irAEs.


Mayce N. Vinson, PharmD Candidate

Latest:

Prescriptive Authority for Pharmacists: Oral Contraceptives

More pharmacists are pushing for prescriptive power, leading to the enactment of new legislation in several states.


Craig L. Kephart

Latest:

Orphan Drugs: Small Markets, Big Opportunity

Orphan drug development has taken off as this segment of the industry has seen impressive growth. Here's an expert analysis of the orphan market by an industry leader outlining the challenges and opportunities.


Robert A. Fulcher, CAE

Latest:

The National Association of Specialty Pharmacy: Charting the Future of Specialty Pharmacy

NASP promotes collaboration among specialty pharmacy stakeholders, emphasizing the importance of education and advocacy.


Jeffrey A. Kyle, PharmD

Latest:

Acute Bacterial Rhinosinusitis: Knowing the Signs

A majority of sinus infections are viral in nature, and a thorough understanding of risk factors and symptoms will help clinicians know when antibiotics are needed.



Darya Inocencio, PharmD

Latest:

Encouraging Immunization Information System Use in Community Pharmacy Practice

Perhaps no sector has benefited more from technological advancement than health care, and within that world, community pharmacy is among the biggest beneficiaries.


Genevieve Regal, PharmD, HC-MBA

Latest:

The Pharmacist’s Role in Maximizing HIV Antiretroviral Therapy

Through ongoing quarterly targeted medication counseling follow-up sessions, the pharmacist may identify ART noncompliance.


AJPB staff

Latest:

Trending News Today: Study Links Prenatal Nicotine Exposure to ADHD in Offspring

Top news of the day from across the health care landscape.


Kirby J. Eng, RPh

Latest:

Medical Benefit Specialty Drug Management–A Call to Action

Specialty drug trend management typically focuses on drug formulations administered via a payer or plan sponsor pharmacy benefit, which overlooks drug spending occurring under a payer or plan sponsor medical benefit.


Jasmine E. Carpenter, PharmD, BCPS, BCPP

Latest:

Opioid Overdose and Naloxone Delivery Devices in the Community Setting

Although naloxone delivery devices are proven to reduce opioid overdoses, challenges persist in increasing the use of these devices in the community setting.



Robert J. Kuhn, BS, PharmD

Latest:

Current and Emerging Therapeutics in Cystic Fibrosis: Ensuring Continuity of Care within the New Treatment Paradigm

This Continuing Education activity is supported by an educational grant from Vertex Pharmaceuticals, Inc.


Karmardi Mills, PhD

Latest:

Drug Coverage and Decision Making in Medicare Part D Enrollees

This pharmacy adjudication, prescription fulfillment study demonstrates how a sudden drop of prescription drug coverage has an effect on Medicare Part D patients' prescription decisions.


JAMIE L. WAGNER, PHARMSD, BCPS

Latest:

Influenza Vaccine–Type Differentiation Updates for 2020

Seasonal influenza is usually active from October to May and is caused by A and B strains of the influenza virus.




Diane Horbacz, MED

Latest:

Exposing Benefits and Barriers: mHealth Use in Managing Hemophilia

Despite medical recommendations, many patients do not consistently remain adherent to their prophylactic schedule.


Jennifer Nessel

Latest:

Pharmacists Address Proper Dosing of Anticoagulants in CAD and PAD

In a Pharmacy Times® Insights series, 2 experts agree that communication is incredibly valuable when discussing guidelines and recommendations.


Silas Inman, OncLive

Latest:

Pre-Chemo Enzalutamide Approved for Metastatic Castration-Resistant Prostate Cancer

The FDA has expanded the approval for enzalutamide (Xtandi) to include the treatment of men with chemotherapy-naive metastatic castration-resistant prostate cancer.


John J. Mahoney, MD

Latest:

Value-Based Design and Prescription Drug Utilization Patterns Among Diabetes Patients

Changes in antidiabetic medication cost sharing due to a value-based pharmacy access program led to increased use of generic and brand antidiabetic oral medications and insulin.


Alicia Rybovic, Senior Editor

Latest:

Health-Systems Pharmacists: Part of a Multidisciplinary Team

Working as a health systems pharmacist is a well-rounded career and offers job fulfillment, satisfaction, and great earning potential.


Milena Anatchkova, PhD

Latest:

A Computerized Asthma Outcomes Measure Is Feasible for Disease Management

The ASTHMA-CAT, an online, patient-based assessment measure, may facilitate asthma care management.


Todd N. Bisping, BS, MBA

Latest:

Caterpillar Breaks New Ground Managing the Prescription Drug Supply Chain

By eliminating waste in the prescription drug supply chain, Caterpillar lowered total drug costs while copayment tiers remained unchanged.


Gary Keil, PhD, RPh

Latest:

Perserverance After Match Day Uncertainty Leads to Opportunity

Match day can be one of the most uplifting, validating, and encouraging of days.


Simon D. Murray, MD

Latest:

NASP 2019: A Doctor's Perspective on Specialty Pharmacy

The annual National Association of Specialty Pharmacy annual meeting shed light on the significant role these caregivers play in patient care.



Jaime Rosenberg

Latest:

Phase 3 Data Favor Bimekizumab Over Placebo in Biologic-Naïve Patients With Psoriatic Arthritis

All primary and ranked secondary endpoints of the study were met at week 16, which were sustained or improved through week 24 and were coupled with patient-reported improvements compared with placebo in treating psoriatic arthritis.


Gina Koskosky

Latest:

ADA's New CEO Takes Over in Time for 78th Scientific Sessions

Tracey D. Brown will welcome 16,000 attendees to the premier diabetes health care conference in her first month as chief executive of the American Diabetes Association.